Velarion Records
Free. Unsubscribe any time.

Verona Pharma plc (VRNA)

Verona Pharma plc filed 21 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 6 reporting owners, covering 32 transactions and 4,248,728 shares. None carries the SEC's AFF10B5ONE flag; all 21 name a plan in a footnote. 3 results prints are on file in the same window.

What stands out

Trades in Verona Pharma plc 32

Adoption dates in Verona Pharma plc 7

Results prints in Verona Pharma plc 3

Trades before a print in Verona Pharma plc 7

Interval to Verona Pharma plc’s next reported results date

How the interval and sources are counted →

Adoption dates Verona Pharma plc states

Filing text: “10b5-1 plan adopted on December 11, 2024”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.